SCHEMBL796559

SCHEMBL796559

Oc1cc(-c2nc3ccccc3s2)ccc1OCCF

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.67
KDM4E B2RXH2 8/20 0.67
NPC1 O15118 7/20 0.67
SMN1; SMN2 Q16637 7/20 0.67
ALDH1A1 P00352 5/20 0.67
KMT2A Q03164 4/20 0.67
HPGD P15428 3/20 0.67
TP53 P04637 3/20 0.67
HSD17B10 Q99714 3/20 0.67
MEN1 O00255 3/20 0.67
NPSR1 Q6W5P4 2/20 0.67
BLM P54132 2/20 0.67
HCRTR1 O43613 1/20 0.67
MAPK1 P28482 1/20 0.67
GLA P06280 3/20 0.60
RAB9A P51151 8/20 0.57
GAA P10253 2/20 0.57
PPARG P37231 1/20 0.57
NCOA2 Q15596 1/20 0.57
NCOA1 Q15788 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796269 0.87 APP (0.55) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL13198323 0.85 SMN1; SMN2 (0.54) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL796277 0.85 MAPT (0.48) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL2247388 0.81 SMN1; SMN2 (1.00) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL30504076 0.81 SMN1; SMN2 (1.00) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL22015459 0.78 MAPT (0.51) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL30466258 0.77 KDM4E (0.69) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL12470903 0.77 KDM4E (0.69) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL30714873 0.76 KDM4E (0.74) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1
SCHEMBL9293186 0.76 KDM4E (0.74) MAPTKDM4ENPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT MAPT 10/4885KDM4E 4716/4885NPC1 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.